444 related articles for article (PubMed ID: 10562298)
1. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
Plotkin LI; Weinstein RS; Parfitt AM; Roberson PK; Manolagas SC; Bellido T
J Clin Invest; 1999 Nov; 104(10):1363-74. PubMed ID: 10562298
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4.
Ahuja SS; Zhao S; Bellido T; Plotkin LI; Jimenez F; Bonewald LF
Endocrinology; 2003 May; 144(5):1761-9. PubMed ID: 12697681
[TBL] [Abstract][Full Text] [Related]
3. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.
Plotkin LI; Lezcano V; Thostenson J; Weinstein RS; Manolagas SC; Bellido T
J Bone Miner Res; 2008 Nov; 23(11):1712-21. PubMed ID: 18597631
[TBL] [Abstract][Full Text] [Related]
4. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
Plotkin LI; Bivi N; Bellido T
Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
[TBL] [Abstract][Full Text] [Related]
5. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
Bellido T; Plotkin LI
Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
[TBL] [Abstract][Full Text] [Related]
6. Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro.
Mathov I; Plotkin LI; Sgarlata CL; Leoni J; Bellido T
J Bone Miner Res; 2001 Nov; 16(11):2050-6. PubMed ID: 11697801
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs.
Plotkin LI; Manolagas SC; Bellido T
Bone; 2006 Sep; 39(3):443-52. PubMed ID: 16627025
[TBL] [Abstract][Full Text] [Related]
8. Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stress in vitro and in vivo in female mice.
Sato AY; Tu X; McAndrews KA; Plotkin LI; Bellido T
Bone; 2015 Apr; 73():60-8. PubMed ID: 25532480
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-induced apoptosis of osteocytic and osteoblastic cells is mediated by TAK1 activation.
Ding H; Wang T; Xu D; Cha B; Liu J; Li Y
Biochem Biophys Res Commun; 2015 May; 460(2):157-63. PubMed ID: 25753204
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.
Plotkin LI; Gortazar AR; Davis HM; Condon KW; Gabilondo H; Maycas M; Allen MR; Bellido T
J Biol Chem; 2015 Jul; 290(31):18934-42. PubMed ID: 26085098
[TBL] [Abstract][Full Text] [Related]
11. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
12. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.
Weinstein RS; O'Brien CA; Almeida M; Zhao H; Roberson PK; Jilka RL; Manolagas SC
Endocrinology; 2011 Sep; 152(9):3323-31. PubMed ID: 21771887
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies using non-traditional bisphosphonates.
Plotkin LI; Buvinic S; Balanta-Melo J
Bone; 2020 May; 134():115301. PubMed ID: 32112989
[TBL] [Abstract][Full Text] [Related]
15. Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k.
Liu Y; Porta A; Peng X; Gengaro K; Cunningham EB; Li H; Dominguez LA; Bellido T; Christakos S
J Bone Miner Res; 2004 Mar; 19(3):479-90. PubMed ID: 15040837
[TBL] [Abstract][Full Text] [Related]
16. Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis.
Gu G; Hentunen TA; Nars M; Härkönen PL; Väänänen HK
Apoptosis; 2005 May; 10(3):583-95. PubMed ID: 15909120
[TBL] [Abstract][Full Text] [Related]
17. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.
Follet H; Li J; Phipps RJ; Hui S; Condon K; Burr DB
Bone; 2007 Apr; 40(4):1172-7. PubMed ID: 17240209
[TBL] [Abstract][Full Text] [Related]
18. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast proliferation and maturation by bisphosphonates.
Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS
Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
